Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, C. Chouaïd, Giannis Mountzios et al.|Journal of Clinical Oncology|2024

Cited by 126